The partnership between Bespak and the MEU will align expert teams from the two organisations who will share knowledge and combine resources in order to fast-track time to clinic, and increase the throughput of low GWP pMDIs moving through clinical evaluation.
We recognise the immense value that Greater Manchester Blood Bikes bring to our community, and we remain committed to assisting them in any way we can.
“We are pleased to play our part as a clinical site in helping EP395 on its development journey towards helping future COPD patients.” – MEU CEO, David Rogers
Excellent to hear from Upstream Bio following MEU’s work with them as a one site solution to their clinical trial leads.
“Doctor Alex Mulvanny, the lead analytical scientist in MEU’s flow laboratory, proved a professional, reliable, engaged, and brilliant partner. Her input and support were vital to the success of our assay development and, eventually, to the application of this assay to the clinical participants enrolled at that clinical site.”
Cancer screening saves thousands of lives each year.
They can detect cancers at an early stage and in some cases, even prevent cancers from developing in the first place.
Manchester-based clinical research facility Medicines Evaluation Unit (MEU) is currently inviting members of the local community to take part in a free cancer screening programme.
We have recently paired with Arxx Therapeutics to help deliver their clinical trial. With the help of MEU and CRO Solutions, Arxx is happy to share that they have completed dosing of all healthy volunteers in their ongoing phase 1 study and successfully initiated the multiple ascending dose part in patients with psoriasis.